Carr Edward Insider Trades

Insider Trading History

Track insider trading activity for Carr Edward. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $5.59M 63,818 shares
Last Trade
Mar 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.3M 16,182 shares
$80.32
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $4.38M 50,000 shares
Last Trade
Mar 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$803k 10,000 shares
$80.32
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $3.82M 43,682 shares
Last Trade
Mar 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$803k 10,000 shares
$80.32
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $3.72M 42,500 shares
Last Trade
Mar 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.41M 17,500 shares
$80.32
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $2.95M 33,682 shares
Last Trade
Mar 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.41M 17,500 shares
$80.32
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $2.44M 27,830 shares
Last Trade
Mar 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.28M 15,852 shares
$80.71
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $1.42M 16,182 shares
Last Trade
Mar 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.3M 16,182 shares
$80.32
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $382k 4,365 shares
Last Trade
Mar 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.92M 23,465 shares
$81.75
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $43.8k 500 shares
Last Trade
Mar 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$319k 3,865 shares
$82.66
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $26.3k 300 shares
Last Trade
Mar 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.7k 200 shares
$83.38
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $0 0 shares
Last Trade
Mar 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$25.7k 300 shares
$85.53
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $4.81M 55,000 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.89M 55,000 shares
$52.46
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $5.25M 60,000 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.32M 60,000 shares
$22.07
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $5.25M 60,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.31M 60,000 shares
$21.77
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF ACCOUNTING OFFICER
Holding Value $7M 80,000 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.43M 80,000 shares
$17.88
$87.53
Magenta Therapeutics
Magenta Therapeutics MGTA
CHIEF ACCOUNTING OFFICER
Holding Value $0 0 shares
Last Trade
Sep 11, 2023 Sale
$67.1k 95,974 shares
$0.70
$0.70
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Financial Officer
Holding Value $2.29M 400,169 shares
Last Trade
Oct 08, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.6k 29,122 shares
$0.95
$5.72
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Financial Officer
Holding Value $2.72M 476,000 shares
Last Trade
Aug 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$600k 476,000 shares
$1.26
$5.72
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Accounting Officer
Holding Value $1.09M 191,291 shares
Last Trade
Apr 05, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$63k 35,000 shares
$1.80
$5.72
Abeona Therapeutics
Abeona Therapeutics ABEO
Chief Accounting Officer
Holding Value $1.29M 226,291 shares
Last Trade
Apr 01, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.8k 20,445 shares
$1.85
$5.72

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up